Act Two Investors
LLY icon

Act Two Investors’s Eli Lilly LLY Stock Holding History

Act Two Investors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.3M Sell
19,267
-35
-0.2% -$41.3K 4.16% 9
2026
Q2 		$23.2M Buy
19,302
+11,128
+136% +$11.4M 4.68% 7
2026
Q1 		$7.52M Sell
8,174
-266
-3% -$270K 1.66% 17
2025
Q4 		$9.07M Sell
8,440
-9
-0.1% -$8.61K 1.63% 17
2025
Q3 		$6.45M Buy
+8,449
New +$6.29M 1.14% 20

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Act Two Investors's LLY Position: Q3 2026 in Review

Act Two Investors reduced its Eli Lilly (LLY) stake by 0.18% in Q3 2026, selling an estimated $41.3K and leaving 19,267 shares worth $22.3M. The position accounts for 4.16% of the portfolio, ranked #9.

Act Two Investors first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $23.2M in Q2 2026. 4,097 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Act Two Investors held 19,267 shares of Eli Lilly worth $22.3M as of Q3 2026.
  • Act Two Investors sold 35 Eli Lilly shares in Q3 2026, an estimated $41.3K.
  • Eli Lilly made up 4.16% of Act Two Investors's portfolio in Q3 2026, its #9 holding.
  • Act Two Investors first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
  • Act Two Investors's Eli Lilly position peaked at $23.2M in Q2 2026.
  • 4,097 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Act Two Investors's 13F filing for Q3 2026, filed 9 Nov 2026.